May 05, 2022
The former CEO of Auspex Pharmaceuticals Inc. will pay just over $56,000 to end both a U.S. Securities and Exchange Commission suit and a related criminal case against him over insider trading accusations that he tipped off his inner circle ahead of his company's $3.2 billion acquisition by Teva.
August 25, 2020
The former CEO of Auspex Pharmaceuticals Inc. tipped off his inner circle ahead of the company's $3.2 billion acquisition by Teva Pharmaceutical Industries Ltd. in 2015, prosecutors and the U.S. Securities and Exchange Commission said in parallel filings in New York federal court Tuesday.